Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News SYBLEU Inc SYBE

SYBLEU Inc. is engaged in the acquisition, licensing and development of medical and veterinary applications. The Company is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The Company is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:SYBE)

Goldman Small Cap Research Publishes New Research Report on Sybleu, Inc.

Accesswire August 24, 2023

Sybleu Inc. Describes Competitive Landscape Around Artificial Intelligence and Machine Learning in Small Molecule Drug Discovery

PR Newswire July 18, 2023

Sybleu Inc. Purchases Fifty Percent Stake In Patent Protected Small Molecule Therapeutic Compounds, Anticipates Synergy With Recently In-Licensed AI/ML Engine

PR Newswire July 11, 2023

Sybleu Inc. Obtains Exclusive License for Artificial Intelligence/ Machine Learning Small Molecule Drug Design Engine

PR Newswire June 27, 2023

SYBLEU Inc. Announces Corporate Strategy and Public Listing

PR Newswire June 6, 2023
View More News ››

Opinion & Analysis (GREY:SYBE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:SYBE)

Sybleu Inc. Purchases Fifty Percent Stake In Patent

NEW YORK, July 11, 2023 /PRNewswire/ -- SYBLEU INC. (OTC PINK: SYBE), a biotechnology company focused on therapies for human...
averagepennies - July 11, 2023

$SYBE Form 8k - July 7th, 2023

Item 1.01 Entry into a Material Definitive Agreement On June 30, 2023 SYBLEU INC. (the “Company”) entered into an agreement...
averagepennies - July 7, 2023

SYBLEU Inc. Announces Corporate Strategy and Public Listing

BRONX, N.Y., June 6, 2023 /PRNewswire/ -- SYBLEU Inc. (OTC PINK: SYBE), a biotechnology company focused on therapies for...
AveragePenny - June 6, 2023
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical ...
View More »